Academic Journal
Q1British Journal of Dermatology
About British Journal of Dermatology
British Journal of Dermatology is a scholarly journal published by Oxford University Press. SCImago 2025 places it in Q1 with an SJR of 2.283 and an H-index of 226.
Its listed coverage is 1892, 1895-1896, 1898, 1901-1903, 1908, 1910-1912, 1916-2026 and its research categories include Dermatology (Q1); Medicine (miscellaneous) (Q1). The 2025 dataset reports 521 documents and 4992 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Autoimmune Bullous Skin Diseases, Dermatology and Skin Diseases, Medicine and Dermatology Studies History, Psoriasis: Treatment and Pathogenesis, Cutaneous Melanoma Detection and Management, Cutaneous lymphoproliferative disorders research.
Recent Research Articles
Latest publications matched automatically by ISSN.
Why do Australian dermatologists screen for Strongyloides stercoralis before dupilumab?
Thomas Lee, Stephen Muhi, Gayle Ross
2026-09-09 · DOI: 10.1093/bjd/ljag382A double-blinded randomized controlled pilot study evaluating the efficacy of siRNA inhibiting SPARC microneedle patch versus siRNA inhibiting SPARC and IL4-RA microneedle patch in reducing scar volume
Eleanor Shu Xian Chai, Delwyn Zhi Jie Lim, Xiahong Zhao, Faith N S Y Tan et al.
2026-09-08 · DOI: 10.1093/bjd/ljag385Immune-Epidermal Dual Targeting in Psoriasis: Emerging Technologies and Translational Therapeutic Strategies
Meijun Liu, Pinzhi Dong, Cong Yang, Xiaorong Xu et al.
2026-09-08 · DOI: 10.1093/bjd/ljag390Primary cutaneous lymphomas: diagnostic burden and determinants of diagnostic delay across the disease spectrum
Joana Calvão, Maria Lourenço, Francisco Martins, Inês Coutinho et al.
2026-09-08 · DOI: 10.1093/bjd/ljag392Personalised mRNA Therapy Comes of Age in Melanoma
Steve Lu, Goran Micevic, John A McGrath
2026-09-08 · DOI: 10.1093/bjd/ljag378An Evolving Landscape in GPP Management: Recibokibart and the Prospect of Broader Access to IL-36 Receptor Blockade
Luis Puig
2026-09-08 · DOI: 10.1093/bjd/ljag396Qualitative assessment of the content validity of pruritus patient-reported outcome measures in mycosis fungoides and Sézary syndrome
Jenny Jung Sun Park, Krithika Nayudu, Caroline Raymundo, Elise Olsen et al.
2026-09-08 · DOI: 10.1093/bjd/ljag379Fear of Losing Repigmentation: An Overlooked Psychosocial Burden in Patients with Vitiligo
Martine Carré, Charles Taieb
2026-09-08 · DOI: 10.1093/bjd/ljag386CD1a-autoreactive T cell sensing of skin barrier compromise
Rosana Ottakandathil Babu, Janina Nahler, Kyla Dooley, Karmella Naidoo et al.
2026-09-08 · DOI: 10.1093/bjd/ljag391Finger-tip Units for topical corticosteroids in eczema: do they work in practice?
Anjali Rameshwaran, Harriet Kelly, Rosie Vincent, Matthew J Ridd et al.
2026-09-08 · DOI: 10.1093/bjd/ljag393Real-world safety profile of spesolimab in generalised pustular psoriasis: expanded access programmes in Japan, China and Argentina
Akimichi Morita, Min Zheng, Furen Zhang, Yu-ling Shi et al.
2026-09-06 · DOI: 10.1093/bjd/ljag338Insulin resistance in psoriasis: beyond comorbidity?
Emma Carroll, Maria Vişan, Maeve Herlihy, Anne-Marie Tobin et al.
2026-09-05 · DOI: 10.1093/bjd/ljag383Distinct genotype-phenotype patterns in non-syndromic hereditary hypotrichosis: a multicenter Chinese cohort
Anqi Zhao, Qiaoyu Cao, Han Chen, Jianwen Han et al.
2026-09-05 · DOI: 10.1093/bjd/ljag384Clinical and Dermoscopic Features of Paediatric Nail Matrix Nevi by Age Group
Jungyoon Ohn, Jung Bin Moon, Soomin Park, Dong Thi Hong Hanh et al.
2026-09-05 · DOI: 10.1093/bjd/ljag380Paper Mills in Dermatology: A Cross-Sectional Study of Retracted Publications
Eugene Tan, Richard Epstein, Shehnaz Ahmed, Hywel C Williams et al.
2026-09-05 · DOI: 10.1093/bjd/ljag381Does time matter? Rethinking the Temporal Dimension of Psoriasis
Soo Bin Ahn, Claudia Furtmüller, Emmanuella Guenova, Wolfram Hoetzenecker et al.
2026-09-03 · DOI: 10.1093/bjd/ljag370Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial
Baoqi Yang, Yuzhen Li, Yu Wang, Liuyi Yang et al.
2026-09-03 · DOI: 10.1093/bjd/ljag369Correction to: Incidence of skin cancer versus overall de novo malignancies among living donor liver transplantation recipients in Taiwan: a cohort study
2026-09-03 · DOI: 10.1093/bjd/ljag359Caution in Interpreting Retrospective Comparisons of Acitretin and Bexarotene in Mycosis Fungoides
Oleg Akilov
2026-09-03 · DOI: 10.1093/bjd/ljag375Microbial-targeted shampoo alleviates dandruff by modifying scalp lipids
Zhijue Xu, Xiaowei Chang, Yaoyao Wu, Dandan Xia et al.
2026-09-03 · DOI: 10.1093/bjd/ljag285Reviews
Community Reviews
Version History
September 8, 2026 at 12:02 am
September 8, 2026